Obstetric and vascular APS: Same autoantibodies but different diseases?
Open Access
- 25 May 2012
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 21 (7), 708-710
- https://doi.org/10.1177/0961203312438116
Abstract
Beta2 glycoprotein I (β2GPI)-dependent antiphospholipid antibodies (aPLs) are the main pathogenic autoantibody population and at the same time the laboratory diagnostic tool for the antiphospholipid syndrome (APS). These antibodies are responsible for both the vascular and the obstetric manifestations of the syndrome but the pathogenic mechanisms behind these manifestations are not the same. For example, thrombotic events do not appear to play a major role in APS miscarriages and a direct reactivity of β2GPI-dependent aPLs on decidual and trophoblast cells was reported. A local expression of β2GPI on these tissues was reported both in physiological conditions and in APS women, thus explaining the local tropism of the autoantibodies. The two hit hypothesis was suggested to explain why the vascular manifestations of APS may occur only occasionally in spite of the persistent presence of aPLs. This is not apparently the case for the obstetric variant of the syndrome, making the difference even more striking. A different pathogenesis may also provide the rationale for the well-known fact that the vascular and the obstetric manifestations may occur independently although in a minority of cases.This publication has 16 references indexed in Scilit:
- Pathogenesis of antiphospholipid syndrome: understanding the antibodiesNature Reviews Rheumatology, 2011
- Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of viewLupus, 2010
- Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?Current Opinion in Rheumatology, 2009
- Antiphospholipid Antibodies and the Antiphospholipid Syndrome: Pathogenic MechanismsSeminars in Thrombosis and Hemostasis, 2008
- Mechanisms of Disease: antiphospholipid antibodies—from clinical association to pathologic mechanismNature Clinical Practice Rheumatology, 2008
- Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) studyBlood, 2007
- Current concepts on the pathogenesis of the antiphospholipid syndromeBlood, 2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndromeBlood, 2003
- Phospholipid Binding Plasma Proteins Required for Antiphospholipid Antibody Detection-An OverviewAmerican Journal of Reproductive Immunology, 1997